j.fonseca
TL2 Moderator · Malmö
Contributes reviews on supplier material. Based in Malmö.
Joined 25 April 2025 · last posted 3d
85Posts here
4Topics
0Solutions
131Likes received
76Likes given
21Badges
81Days visited
847Posts read
Recent activity
Full stream-
Request: tag synonyms surfaced in search Replied, post #26 · Meta › Feature requests · 25 Jul 2026 · 7 likes Worth separating two things that post #22 runs together. Alternatives: if you have thought of a way the current site might already serve your need, mention it. It helps…
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #115 · Evidence › Journal club · 25 Jul 2026 · 5 likes SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the cardiovascular evidence to the oral formulation. Note that oral bioavailability is lower…
-
Talking to a therapist about this specifically Replied, post #22 · Wellbeing › Mental health · 18 Jul 2026 · 5 likes I read post #20 twice before replying, because I had assumed the opposite. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write…
-
Molecular mass of semaglutide and why the figure differs between sources Replied, post #103 · Compounds › Semaglutide · 17 Jul 2026 · 13 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
What a reversed-phase purity number actually is Replied, post #60 · Analytics › HPLC & UHPLC · 16 Jul 2026 · 0 likes Reversed-phase separates on hydrophobicity. A peptide is retained on a non-polar stationary phase and eluted by increasing organic solvent. For peptides the mobile…
-
What to bring: records that a clinician can actually use — a second dataset Replied, post #21 · Clinical › Prescriber conversations · 10 Jul 2026 · 4 likes How to ask for what you need: rather than "should I take this", frame it as "I understand the evidence for this shows X benefit in people with my condition; would it be…
-
Ultrasound and skinfolds: operator dependence in practice Replied, post #44 · Outcomes › Body composition · 5 Jul 2026 · 9 likes This follows post #41 rather than contradicting it. Visceral fat: DXA does not distinguish visceral (organ-associated) fat from subcutaneous fat. That distinction might…
-
Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #61 · Practice › Administration · 26 Jun 2026 · 22 likes Air bubbles in a subcutaneous injection: the honest risk assessment is low. Tiny air bubbles in subcutaneous tissue do not behave like an air embolism in a blood…
-
Journal club: SELECT, absolute risk, and how it was reported Replied, post #3 · Evidence › Journal club · 23 Jun 2026 · 1 like I read the opening post twice before replying, because I had assumed the opposite. PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not…
-
A supplier who responds to a discrepancy with silence — what changed since Replied, post #66 · Sourcing › Red flags · 19 Jun 2026 · 0 likes This follows post #63 rather than contradicting it. Unresponsiveness: a supplier that does not reply to reasonable requests for documentation or clarification is…
-
Does dual agonism explain the effect size, or is it dose? Replied, post #43 · Compounds › Tirzepatide · 18 Jun 2026 · 8 likes Worth separating two things that post #39 runs together. Dual agonism versus dose: how much of tirzepatide's effect is the GIP component and how much is simply…
-
Why we ask for units every single time, with three examples of what goes wrong Replied, post #16 · Start Here › How to Ask · 3 Jun 2026 · 4 likes Disagreeing with an answer you got: cite what you disagree with, say what contradicts it, and ask which one holds. Do not open with "I think you are wrong". Lead with…